Home › Funds › TREMBLANT CAPITAL GROUP › ALNY
TREMBLANT CAPITAL GROUP position in ALNY
ALNYLAM PHARMACEUTICALS INC · Health Care
TREMBLANT CAPITAL GROUP reported holding 109,455 shares of ALNY (ALNYLAM PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$27.0M, representing 0.83% of its reported portfolio and ranking #39 among its reported holdings. TREMBLANT CAPITAL GROUP has disclosed ALNY holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How TREMBLANT CAPITAL GROUP's ALNY position evolved
TREMBLANT CAPITAL GROUP first disclosed a stake in ALNY in Q4 2025 at 110,132 shares (US$43.8M). Across 4 filings, TREMBLANT CAPITAL GROUP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 109,455 shares valued at US$27.0M — an increase of 16,515 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 110.13K | $43.79M | New |
| Q1 2026 | 94.56K | $31.29M | Reduce |
| Q2 2026 | 92.94K | $27.98M | Reduce |
| Q3 2026 | 109.45K | $27.01M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ALNY and 13F data
ALNY (ALNYLAM PHARMACEUTICALS INC) is a Health Care company. 30 other funds we track also report a position in ALNY — the largest reported positions include T. Rowe Price Investment Management, Inc. (US$1.70B), Baillie Gifford & Co (US$1.36B), Orbis Allan Gray Ltd (US$597.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ALNY
- T. Rowe Price Investment Management, Inc. 5.64M sh · $1.70B · Q2 2026
- Baillie Gifford & Co 5.49M sh · $1.36B · Q3 2026
- Orbis Allan Gray Ltd 2.42M sh · $597.40M · Q3 2026
- TWO SIGMA ADVISERS, LP 1.13M sh · $450.36M · Q4 2025
More on TREMBLANT CAPITAL GROUP
FAQ
How long has TREMBLANT CAPITAL GROUP held ALNY?
TREMBLANT CAPITAL GROUP has disclosed ALNY holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is TREMBLANT CAPITAL GROUP's current position in ALNY?
As of Q3 2026, TREMBLANT CAPITAL GROUP holds 109.45K shares of ALNY (ALNYLAM PHARMACEUTICALS INC), valued at $27.01M, representing 0.83% of its reported portfolio and ranking #39.
Has TREMBLANT CAPITAL GROUP been buying or selling ALNY?
In the latest 13F filing (Q3 2026), TREMBLANT CAPITAL GROUP increased its position in ALNY.
Which other funds hold ALNY?
Other major institutional holders of ALNY include T. Rowe Price Investment Management, Inc., Baillie Gifford & Co, Orbis Allan Gray Ltd, among 30 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.